$AHCO Income Statement | Understand Stock

$AHCO

$5.93 -$0.09 (1.5%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Grant income
Net revenue
Costs and expenses:
Cost of net revenue
General and administrative expenses
Depreciation and amortization, excluding patient equipment depreciation
Goodwill impairment (note 7)
Total costs and expenses
Gain on sale of businesses (note 4)
Operating income (loss)
Interest expense, net
Loss on extinguishment of debt
Change in fair value of warrant liability (note 13)
Change in fair value of contingent consideration common shares liability (note 11)
Other loss, net
(Loss) income before income taxes
Income tax expense (benefit)
Net (loss) income
Income attributable to noncontrolling interest
Net (loss) income attributable to AdaptHealth Corp.
Weighted average common shares outstanding - basic (in shares)
Weighted average common shares outstanding - diluted (in shares)
Basic
Basic net (loss) income per share (in dollars per share)
Diluted net (loss) income per share (in dollars per share)

Comments